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Hesperidin is a flavonoid found in fruits of the genus Citrus [1]. 
It is reported its role in the decrease of Th2-cytokines in murine 
asthma models [2, 3]. However, the influence of hesperidin on 
lymphoid tissues and on specific antibody synthesis has not been 
studied in depth. The aim of this study was to establish the influ-
ence of hesperidin on immunized rats. For this, Lewis rats were 
either orally sensitized with ovalbumin (OVA) and cholera toxin 
(CT) and fed 0.5% hesperidin diet, or intraperitoneally (ip) immu-
nized with OVA, Bordetella pertussis toxin and Alum and admin-
istered by oral gavage 100 or 200 mg of hesperidin per kg of body 
weight.
In the first experimental design, hesperidin diet modified the 
effector lymphoid tissue compartments increasing the proportion 
of TCRγδ cells among intraepithelial lymphocytes (IEL) and de-
creasing that one from lamina propia lymphocytes (LPL). Hes-
peridin diet did not produced modifications on the lymphocyte 
composition of the inductive sites. In the second experimental de-
sign, hesperidin increased the proportion of TCRαβ+ cells and de-
creased those of CD45RA+ and CD8+CD25+ lymphocytes from 
mesenteric lymph nodes lymphocytes (MLNL). Moreover, hesper-
idin induced higher production of IFN-γ in stimulated MLNL. 
Nevertheless, in both designs, the hesperidin did not modify serum 
specific antibody production neither intestinal IgA content. 
In conclusion, hesperidin possesses immunoregulatory prop-
erties in the intestinal immune response although the synthesis of 
systemic antibodies is not affected. 
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The aim of this work was to evaluate, for further application in 
functional food development, some probiotic properties and the 
response to acidic and heat shock stresses of six lactic acid bacteria 
(LAB) isolated from Mexican cooked meat products, namely, one 
Enterococcus faecium UAM1 strain and five Pediococcus pento-
saceus strains.
This study, revealed that under simulated human gastric condi-
tions, the Enterococcus strain had a high resistance pattern, supe-
rior to that of the Pediococcus strains. Exposure to a simulated 
intestinal stress environment did not greatly affect the survival of 
any of the LAB strains investigated. In addition, high levels of co-
aggregation of the potentially probiotic LAB with Gram-positive 
and Gram-negative bacterial pathogens were detected. The adher-
ence of E. faecium UAM1 to human Caco-2 cell line (around 20%) 
was significantly higher to that obtained with the five P. pentosa-
ceus strains (2%–4%) and Lactobacillus acidophilus LA-5 (6%), a 
commercial probiotic strain. 
Thermotolerance, above 65ºC, of all of the tested strains was 
corroborated by DT values. Additionally, a differential proteomic 
stress response of enterococcal and pediococcal strain was detect-
ed by LC-M, upon exposure to heat and acidic stresses. The overall 
results indicate that E. faecium UAM1 has thermo-tolerant prop-
erties for survival during the preparation of mexican cooked meat. 
Moreover, it has probiotic properties that predict its capability to 
colonize in competition with pathogen the intestinal tract. Thus, 
this bacterium deserves further investigation for its potential as a 
component of functional food.
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The objective of the present study was to evaluate the effect of 
chronic sweetener consumption on BMI, glucose and adipokines 
in peripheral blood. The ingestion of non-caloric sweeteners in-
creases exponentially, since in many commercial products they use 
as a strategy to reduce calorie consumption [1], control body 
weight [2] and sometimes glycemia; however its use today is still 
controversial, as well as the effects of its long-term use [3]. Thirty-
two CD1 male mice 21-day old were divided into 4 groups: Control 
(CL), Sucrose (Suc), Sucralose (Sucl) and Stevia (St). BMI, Glucose 
(mg/dl), TNF-α (pg/mL) and Resistin (pg/mL) were determined. 
The sweetener was given daily diluted in ultrapure water with the 
following concentration: Sucrose (41.6 mg/ml), Sucralose and Ste-
via (4.1 mg/ml), 8–13 h for 84 days. Food and water without sweet-
ener was given ad libitum. BMI and glycemia were recorded week-
ly, serum TNF-α and Resistin levels were obtained. The BMI (F = 
1,297, p = 0.293) and glucose (F = 0.923, p = 0.443) remained un-
changed at the end of the 84 days of treatment. There was no sta-
tistically significant difference in blood levels of TNF-α (F = 0.571, 
p = 0.639) and resistin (F = 1,918, p = 0.150) in any of the study 
groups. In this study the administration of the sweetener was in-
termittent (alternating periods with/without exposure), which 
may explain that there are no significant changes in adipokine 
blood levels. 
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Aim: The aim of the study was to analyze the effect of Omega-3 
fatty acids extracted from microalgae on the IFN-γ concentra-
tions. Diabetes Mellitus is considered a chronic disease character-
ized for an inflammatory state in which many cytokines are con-
tinuously released including Interferon gamma (IFN-γ) [1]. Ome-
ga-3 fatty acids are well known for reducing inflammatory states 
such as in diabetes and contribute to stop the development of 
complications. 
Method: 30 db/db male mice 8 weeks old were randomly as-
signed either to a control group (CL); a supplemented with Lyoph-
ilized microalgae EPA+DHA fatty group (LY); a supplemented 
with saturated fatty acids (pure coconut oil) group (SAT) or a group 
fed with a microalgae EPA+DHA modified diet (MD). Experimen-
tal study was conducted from the 8th to the 16th week of life. After 
treatment, blood lymphocytes where isolated and flow cytometry 
was conducted. 
Results: One-way ANOVA was performed and showed signifi-
cant differences between treatments (F = 1009.208, p < 0.001). LY 
and MD group showed significantly lower concentrations when 
compared to Control group (Bonferroni, p < 0.001) and SAT group 
was significantly higher also when compared to Control group 
(Bonferroni, p < 0.001). 
Conclusions: The consumption of microalgae Omega-3 fatty 
acids whether from diet or supplemented decreases IFN-γ concen-
trations which may reduce the risk of complications in Diabetes 
Mellitus.
D
ow
nl
oa
de
d 
by
: 
16
1.
11
1.
10
5.
10
0 
- 7
/1
7/
20
17
 1
:4
1:
39
 P
M
